Soybean isoflavone extract improves glucose tolerance and raises the survival rate in streptozotocin-induced diabetic rats |
Shim, Jee-Youn
(Department of Food Science and Nutrition, Kyungpook National University)
Kim, Kwang-Ok (Department of Food Science and Nutrition, Kyungpook National University) Seo, Bo-Hyun (Department of Food Science and Nutrition, Kyungpook National University) Lee, Hye-Sung (Department of Food Science and Nutrition, Kyungpook National University) |
1 | Anderson JW, Blake JE, Turner J & Smith BM (1998). Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 68:1347S-1353S DOI |
2 | Bhatena SJ & Velasquez MT (2002). Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76:1191-1201 DOI |
3 | Constantinou AI, Lantvit D, Hawthorne M, Xu X, van Breemen RB & Pezzuto JM (2001). Chemopreventive effects of soy protein and purified isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr Cancer 41:75-81 DOI |
4 | Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR & Kurzer MS (1999). Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endo Metab 84:3479-3484 DOI |
5 | Dyrskog SEU, Jeppesen PB, Colombo M, Abudula R & Hermansen K (2005). Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats. Clin Exper 54:1181-1188 |
6 | Hermansen K, Sondergaard M, Hoie L, Carstensen M & Brock B (2001). Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diab Care 24:228-233 DOI ScienceOn |
7 | Kawano-Takahashi Y, Ohminami H & Okuda I (1986). Effect of soy saponins on thioglucose (GTG) induced obesity in mice. Int J Obes 10:293-302 |
8 | Lajolo FM, Hassimotto NMA & Genovese MI (2005). Isoflavone profile and antioxidant activity of Brazilian soybean varieties. Food Sci Technol Int 11:205-211 DOI |
9 | Lee DS & Lee SH (2001). Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor. Fed Eur Biochem Soc letters 501:84-86 DOI ScienceOn |
10 | Ren MQ, Kuhn G, Wegner J & Chen J (2001). Isoflavone, substances with multi-biological and clinical properties. Eur J Nutr 40:135-146 DOI |
11 | Ruiz-Larrea MB, Mohan AR, Paganga G., Miller NJ, Bolwell GP & Rice-Evans CA (1997). Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 26:63-70 DOI |
12 | Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S & McGrath BP (2001). Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endo Metab 86:3053-3060 DOI |
13 | Teixeira SR, Tappenden KA, Carson L, Jones R, Parabhudesai M, Marsl WP & Erdman JW Jr, (2004). Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134:1874-80 |
14 | Goodman-Gruen D & Kritz-Silverstein D (2001). Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131:1202-1206 |
15 | Vedavanam K, Srijayanta S, O'Reilly J, Raman A & Wiseman H (1999). Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phyto Res 13:601-608 DOI ScienceOn |
16 | Zhang M, Xie X, Lee AH & Binns CW (2004). Soy isoflavone intake are associated with reduced risk of ovarian cancer in southeast China. Nutr Cancer 49:125-130 DOI ScienceOn |
17 | Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL & Lamia CA (2000). Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study. Menopause 7:236-242 DOI |
18 | Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y & Esmaill-Zadeh A (2003). Beneficiary effect of dietary soy protein on lowering plasma level lipids and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 57:1292-1294 DOI ScienceOn |
19 | Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KD, Weinberg CR, Haney AF, Wilcox AJ & Mclachlan JA (1995). Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 80:1685-1690 DOI |
20 | Lee SK, Yoon S & Kwon DJ (2000). Estimated isoflavone intake from soy products in Korean middle-aged women. J Korean Soc Food Sci Nutr 29:948-956 과학기술학회마을 |
21 | Setchell KD (2001). Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 20:354S-362S DOI |
22 | Naaz A, Yellayi S & Zakroczymski MA (2003). The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 144:3315-3320 DOI ScienceOn |
23 | Hsu CS, Chiu WC & Yeh SH (2003). Effects of soy isoflavone supplementation on plasma glucose, lipids and antioxidant enzyme activities in streptozotocin-induced diabetic rats. Nutr Res 23:67-75 DOI ScienceOn |
24 | Chen X & Anderson JJB (2001). Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutr Cancer 41:156-170 DOI ScienceOn |
25 | Anderson JW, Smith BM & Washnock CS (1999). Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr 70:464S-474S DOI |
26 | Bartke A, Peluso MR, Moretz N, Wright C, Bonkowski M, Winters TA, Shanahan MF, Kopchick JJ & Banz WJ (2004). Effects of soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice. Horm Meta Res 36:550-558 DOI ScienceOn |
27 | Washburn S, Burke GL, Morgan T & Anthony M (1999). Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in premenopausal women. In B,G, Wrem (Ed.), Menopause 6:7-13 |
28 | Wang HJ & Murphy PA (1994). Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666-1673 DOI ScienceOn |
29 | Bosello O, Cominacini L, Zocca I, Garbin U, Compri R, Davol A & Brunetti L (1998). Short- and long-term effects of hypocaloric diets containing proteins of different sources on plasma lipids and apoproteins of obese subjects. Ann Nutr Metab 32:206-214 DOI |
30 | Ali AA, Velasquez MT, Hansen CT, Mohamed AI & Bhathena SJ (2005). Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes. J Nutr Biochem 16:693-699 DOI ScienceOn |
31 | Humphrey LL & Ballard DJ (1990). Renal complications in noninsulin- dependent diabetes mellitus. Clin Ger Med 6, 807-825 DOI |
32 | Aoyama T, Fukui K, Takamatsu K, Hashimoto Y & Yamamoto T (2000). Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK). Nutrition 16:349-354 DOI ScienceOn |
33 | Lee JS (2006). Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocininduced diabetic rats. Life Sci 79:1578-1584 DOI ScienceOn |
34 | Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW & Toda T (2000). Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852 DOI |
35 | Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA & Josse RG. (2002). Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76:365-372 DOI |
36 | Ali AA, Velasquez MT & Hansen CT (2004). Effects of soy bean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Biochem 15:583-590 DOI ScienceOn |
37 | Lavigne C, Marette A & Jacques H (2000). Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278:491-500 DOI |
38 | Reitman S & Frankel S (1957). A colorimetic method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am J Clin Pathol 2: 56-63 |
39 | Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, Doerge D, Fontana J, Chinni S, Davis J, Forman J, Wood DP & Kucuk O (2003). Soy isoflavones in the treatment of prostate cancer. Nutr Cancer 47:111-117 DOI ScienceOn |
40 | Somekawa Y, Chiguchi M, Ishibashi T & Aso T (2001). Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. J Obst Gynecol 97: 109-115 DOI ScienceOn |
41 | Yamashita T, Sasahara T, Pomeroy SE, Collier G. & Nestel PG (1998). Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. Metabolism 47:1308-1314 DOI ScienceOn |
42 | Satio M (1991). Effect of soy peptides on energy metabolism in obese animals. Nutr Sci Soy Protein 12:91-94 |
43 | Setchell KD & Cassidy A (1999). Dietary isoflavones: Biological effects and relevance to human health. J Nutr 129:758S-767S DOI |
44 | Taha SA & Wasif MM (1996). Hypoglycemic effect and protein nutritive quality of soy and methionine supplemented whole durum pasta products. Nahrung 40:281-287 DOI ScienceOn |
45 | Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P & Kukreja SC (1996). Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161-167 DOI |
46 | Tham DM, Gardner CD & Haskell WL (1998). Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endo Metab 83:2223-2235 DOI |
47 | Wei H, Bowen R, Cai Q, Barnes S & Wang Y (1995). Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208:124-130 |